Mycoses Study Group Education and Research Consortium
Mycoses Study Group Education and Research Consortium
Mycoses Study Group Education and Research Consortium is ranked among medical research organizations in Irondale, AL, with an America's Best Score of 66 out of 100, based on its 2024 Form 990.
Mycoses Study Group Education and Research Consortium is a 501(c)(3) organization, classified under Medical Research (NTEE H05). Contributions are tax-deductible.
1330 Creekside Gln, Irondale, AL 35210-2192
In fiscal year 2024 it reported $470,737 in revenue and $398,802 in expenses, with contributions making up 98.3% of revenue.
To provide continuing medical education and a medical/scientific think tank for evidence-based medicine in the prevention, treatment and maintenance of patients at risk for or afflicted with invasive fungal infections while also serving as a resource and support for patients and caregivers who are affected by these serious rare diseases.
Main program · fiscal year 2024
To provide continuing medical education and a medical/scientific think tank for evidence-based medicine in the prevention, treatment and maintenance of patients at risk for or afflicted with invasive fungal infections while also serving as a resource and support for patients and caregivers who are affected by these serious rare diseases.$330,728 spent
Where each dollar went · fiscal year 2024
Of every dollar it spent, 83¢ went to programs, 17¢ to management and 0¢ to fundraising.
Programs $330,728
Management $68,074
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
83%
Meets
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$470,737Fiscal year 2024
Expenses$398,802Fiscal year 2024
Total assets$476,880Fiscal year 2024
Total liabilities$43,600Fiscal year 2024
Fiscal year ending December2024
Revenue$470,737
Expenses$398,802
Net income$71,935
Net assets$433,280
Notable sources of revenue
Percent of total revenue
Contributions
$462,510
98.3%
Program services
$0
0.0%
Investment income
$5,391
1.1%
Other (net)
$2,836
0.6%
Assets / debt
Total assets
$476,880
Total liabilities
$43,600
Net assets
$433,280
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$120,548
Expenses$146,968
Net income−$26,420
Net assets$352,723
Notable sources of revenue
Percent of total revenue
Contributions
$120,528
100.0%
Program services
$0
0.0%
Investment income
$20
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$422,723
Total liabilities
$70,000
Net assets
$352,723
Compensation
Officers and key employees
$0
Share of expenses
0.0%
Fiscal year ending December2022
Revenue$393,086
Expenses$375,141
Net income$17,945
Net assets$379,143
Notable sources of revenue
Percent of total revenue
Contributions
$329,893
83.9%
Program services
$63,175
16.1%
Investment income
$18
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$379,143
Total liabilities
$0
Net assets
$379,143
Compensation
Officers and key employees
$0
Share of expenses
0.0%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?